Electromagnetic Resonance Disease Detection System
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current COVID-19 testing methods are slow, require extensive use of costly supplies and personal protective equipment (PPE), and involve direct patient contact, posing risks to medical personnel and inefficiencies in administrative processes.
Innovation Solution
An electromagnetic resonance-based disease detecting system that uses a spectrum analyzer, radiating and receiving antennas, and a processor to rapidly detect the presence of COVID-19 by generating and analyzing resonant frequencies, allowing for remote testing without the need for reagents or PPE, and enabling quick identification and isolation of infected patients.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current assay-based testing methods are used, then disease diagnosis can be achieved, but testing time is prolonged (hours or days) and administrative effort increases
Solution Approach 1:
The patent replaces mechanical/chemical testing systems (assay-based methods requiring physical contact, swabs, reagents) with an electromagnetic field-based detection system. The system uses electromagnetic radiation to interact with molecular vibrations of viral components, enabling remote, rapid detection without physical sampling or chemical reactions, thus reducing testing time from hours/days to minutes while maintaining diagnostic accuracy
Solution Approach 2:
The patent exploits molecular vibration resonances of viral components (proteins, nucleic acids) at specific infrared frequencies. By tuning electromagnetic radiation to match these characteristic vibrational frequencies, the system detects unique spectral signatures of the virus, enabling rapid identification without time-consuming chemical assays while preserving measurement precision
2Measurement precision
If current testing methods are used, then disease detection is possible, but extensive testing supplies (swabs, reagents) and PPE are required
Solution Approach 1:
The patent eliminates the need for physical testing supplies (swabs, reagents, consumables) by replacing them with an electromagnetic field-based detection system. The system uses remote electromagnetic radiation to interact with viral molecules, requiring no physical contact or chemical materials, thus reducing consumption of testing supplies and PPE to near zero
Solution Approach 2:
The patent creates an electromagnetic 'copy' or spectral fingerprint of the viral components by detecting their characteristic vibrational frequencies. This electromagnetic signature serves as a substitute for physical viral samples, allowing detection without consuming actual biological materials or requiring physical handling that would necessitate PPE
3Measurement precision
If current testing methods are used, then patient testing can be performed, but direct person-to-person contact is required, exposing medical personnel and patients
Solution Approach 1:
The patent replaces direct physical contact testing with remote electromagnetic field-based detection. The system uses electromagnetic radiation that can penetrate or interact with patients from a distance, eliminating the need for medical personnel to physically contact patients or handle biological samples, thus removing the requirement for PPE and eliminating exposure risks for both personnel and patients
Solution Approach 2:
The patent introduces electromagnetic radiation as an intermediary between the detection system and the patient. Instead of direct contact between medical personnel and patients, the electromagnetic field serves as the medium that carries information about viral presence, allowing remote, non-invasive testing that protects both parties from exposure while maintaining diagnostic accuracy
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system enables rapid detection of COVID-19 in seconds, reduces the need for testing supplies and PPE, minimizes exposure to medical personnel, and facilitates immediate database updates, thereby improving efficiency and safety during the pandemic.
Implementation Method 1
a spectrum analyzer assembly comprising one of a spectrum analyzer with an internal tracking generator or a spectrum analyzer with a separate signal generator, which output is configured to generate a resonant frequency signal that carries at least one frequency at which reference materials relate to a disease condition resonate
Implementation Method 2
a radiating antenna electronically connected to the output of the spectrum analyzer assembly and configured to radiate a subject with an electromagnetic field based on the resonant frequency signal
Implementation Method 3
a receiving antenna configured to receive the subject spectrum
Data Source
AI summary
An electromagnetic resonance-based disease detecting system may comprising a spectrum analyzer assembly comprised of one of a spectrum analyzer with an internal tracking generator or a spectrum analyzer with a separate signal generator, a radiating antenna electronically connected to the spectrum analyzer assembly output and configured to radiate a subject with an electromagnetic field based on a resonant frequency signal, wherein radiating a subject with the electromagnetic field generates a subject spectrum; a receiving antenna configured to receive the subject spectrum; a spectrum analyzer electronically connected to the receiving antenna and configured to receive the subject spectrum from the receiving antenna; and a processor, the processor being operatively connected to the spectrum analyzer assembly, the radiating antenna, the receiving antenna, and the spectrum analyzer, wherein the processor is configurable to store and control the resonant frequency signal generated by the spectrum analyzer assembly output control the electromagnetic field radiated from the radiating antenna; and, compare the received subject spectrum to the generated resonant frequency signal using the spectrum analyzer assembly input controlled by the processor to determine an absence or a presence of the disease condition without the use of chemical reagents or testing supplies.